Undetectable serum calcidiol: Not everything that glitters is gold

Clinical Kidney Journal

Volumn 5, Issue 1, 2012, Pages 37-40

  Gallegos Bayas, Gioconda ^a   Pascual Pareja, José Francisco ^b   Sanchez Niño, Maria D ^b   Manzarbeitia, Felix ^b   Ortiz, Alberto ^b  

^a Centro de Salud Barrio del Pilar   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

1,25(OH)2 vitamin D; 25 hydroxyvitamin D 1 hydroxylase; chronic tophaceous gout; CYP24; vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; ALENDRONIC ACID; ALLOPURINOL; BICARBONATE; CALCIDIOL; CALCIDIOL 1 MONOOXYGENASE; CALCIFEDIOL; CALCIUM; COLCHICINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; PARATHYROID HORMONE; PREDNISONE; UNCLASSIFIED DRUG; URIC ACID; VITAMIN D;

AGED; ARM; ARTICLE; BIOPSY; BUTTOCK; CALCIUM BLOOD LEVEL; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC TOPHACEOUS GOUT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG DOSE INCREASE; ENZYME ACTIVITY; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; GLOMERULUS FILTRATION RATE; GOUT; GRANULOMATOSIS; HAND; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MULTINUCLEAR CELL; NORMOCHROMIC NORMOCYTIC ANEMIA; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; THIGH; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84862101092     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ndtplus/sfr121     Document Type: Article

References (13)

1. Rojas-Rivera J, De La Piedra C, Ramos A et al. The expanding spectrum of biological actions of vitamin D. Nephrol Dial Transplant 2010; 25: 2850-2865
2. Torregrosa JV, Cannata Andia J, Bover J et al. [SEN Guidelines. Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic renal disease patients]. Nefrologia 2008; 28 (Suppl 1): 1-22
3. Bénéteau-Burnat B, Baudin B. Angiotensin-converting enzyme: clinical applications and laboratory investigations on serumand other biological fluids. Crit Rev Clin Lab Sci 1991; 28: 337-356
4. Jacobs TP, Bilezikian JP. Review: rare causes of hypercalcemia. J Clin Endocrinol Metab. 2005; 90: 6316-6322
5. Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 2000; 6: 442-447 (Pubitemid 30637660)
6. Kallas M, Green F, Hewison M et al. Rare causes of calcitriolmediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab 2010; 95: 3111-3117
7. Sachdeva A, Goeckeritz BE, Oliver AM. Symptomatic hypercalcemia in a patient with chronic tophaceous gout: a case report. Cases J 2008; 1: 72
8. Boon ES, Cozijn D, Brombacher PJ. Enhanced production of calcitriol, and hypercalcaemia in a patient with sarcoidosis provoked by daily intake of calciol. Eur J Clin Chem Clin Biochem 1993; 31: 679-681 (Pubitemid 23323882)
9. Sandler LM, Winearls CG, Fraher LJ et al. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med 1984; 53: 165-180 (Pubitemid 14044801)
10. Hsu CH, Patel SR, Young EW et al. Effects of purine derivatives on calcitriol metabolism in rats. Am J Physiol 1991; 260: F596-F601
11. Vanholder R, Patel S, Hsu CH. Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure. J Am Soc Nephrol 1993; 4: 1035-1038
12. Hayes ME, Denton J, Freemont AJ et al. Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases. Ann Rheum Dis 1989; 48: 723-729 (Pubitemid 19225043)
13. Ren S, Nguyen L, Wu S et al. Alternative splicing of vitamin D- 24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J Biol Chem 2005; 280: 20604-20611 (Pubitemid 40776763)